METAvivor Moves Peer-to-Peer Fundraising to Bloomerang

METAvivor has transitioned from GoFundMe Pro (formerly Classy) to Bloomerang Fundraising for our Peer-to-Peer fundraising efforts. As of this fall, fundraising pages on GoFundMe Pro will no longer be active. […]
A Personal Update and What’s Ahead at METAvivor

Letter from the President Kelly Shanahan, M.D. Time really does move faster as we get older – or have a MBC diagnosis. It’s crazy to think that summer is almost […]
August 2026 Advocacy Update

As summer winds down, METAvivor’s Stage IV Stampede and Summit is approaching quickly, and we hope you’ll join us in Washington, DC. If you haven’t already, please mark your calendar […]
Letter From American Cancer Society Cancer Action Network (ACS CAN)

METAvivor Signs On to Remove Financial Barriers to Clinical Trials METAvivor has joined 128 other patient advocacy groups, public health organizations, and professional societies in urging the U.S. Department of […]
Challenge to Grant Review Process Sought by OMB-2026-0034

METAvivor submitted a formal response to OMB-2026-0034 opposing proposed changes to federal research funding. METAvivor submitted a formal response to the Office of Management and Budget regarding the proposed Uniform […]
Support Legislation Removing Barriers to Clinical Trials

METAvivor signed onto a letter supporting the Clinical Trial Modernization Act. METAvivor has joined nearly 200 patient advocacy, public health, and health care organizations in supporting the bipartisan Clinical Trial […]
Letter from Alliance for Breast Cancer Policy

METAvivor Leads the Call for Better Cancer Registry Data As a proud Steering Committee member of the Alliance for Breast Cancer Policy, METAvivor was proud to sign on to this […]
June 11 PCORI Letter from METAvivor

METAvivor speaks out against proposed elimination of funding for the PCORI Trust Fund. PCORI’s patient-centered research fills a critical gap in the research landscape for the MBC community. Read the […]
June 11 Registries Letter from METAvivor

METAvivor is weighing in to make sure Congress supports America’s Cancer Registries as they set funding levels for 2027. Consistent and strong support for these registries is essential in our […]
Webinar Recap: The 4 Ws of Biomarker Testing

On October 29, METAvivor partnered with Menarini Group and Stemline to present The 4 Ws of Biomarker Testing, a powerful and informative webinar designed to demystify the role of biomarkers […]
Advocacy in Action: Rep. Morelle Champions Cancer Drug Parity and MBC Access to Care

In a heartfelt video message shared at the Stage IV Stampede Advocacy Breakfast, Representative Joe Morelle spoke as both a legislator and a grieving father, having lost his daughter to […]
270+ Landmarks Across the Globe and Star Talent Unite for #LightUpMBC to Fund Stage 4 Breast Cancer Research

Watch #LightUpMBC LIVE streaming on October 13 at 8 ET / 5 PT NEW YORK, NY, October 9, 2025 – Metastatic breast cancer (MBC), also known as Stage 4, takes […]